Business Context and Reporting Period
Company: Coca-Cola Europacific Partners Plc (CCEP)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: December 10, 2025 – December 16, 2025
Business Overview: CCEP is a leading consumer goods company serving nearly 600 million consumers across 31 countries. It is listed on Euronext Amsterdam, NASDAQ, the London Stock Exchange, and Spanish Stock Exchanges.
Key Financial Metrics and Transactions
This filing details daily share repurchase transactions under the Company's ongoing buyback programme. No revenue, profit, or cash flow data is provided in this specific document.
| Date of Purchase | US Venues Shares | London Venues Shares | Total Shares | US VWAP (USD) | London VWAP (GBP) |
|---|---|---|---|---|---|
| Dec 9, 2025 | 36,817 | 24,449 | 61,266 | 90.7897 | 68.0682 - 68.2572 |
| Dec 10, 2025 | 36,738 | 24,498 | 61,236 | 89.9161 | 67.5582 - 67.6510 |
| Dec 11, 2025 | 37,047 | 29,547 | 66,594 | 90.0101 | 67.4936 - 67.5870 |
| Dec 12, 2025 | 37,960 | 20,000 | 57,960 | 90.2094 | 67.1435 - 67.1866 |
| Dec 15, 2025 | 37,600 | 0 | 37,600 | 91.4696 | N/A |
Programme Details: The purchases are part of a EUR 1 billion share buyback programme announced on February 14, 2025. All repurchased shares are cancelled.
Material Changes and Programme Updates
- Final Tranche Adjustment: On December 11 and 12, 2025, the Company announced an adjustment to the final tranche of the buyback programme (expected completion by December 19, 2025). While the aggregate amount for the tranche remains EUR 382,000,000, the allocation for US Trading Venues was increased from EUR 280,000,000 to EUR 280,394,000.
- Trading Activity: Significant repurchase activity occurred on US Trading Venues (Nasdaq) throughout the week, with prices ranging between approximately USD 89.19 and USD 92.07. London Trading Venues activity ceased on December 15, 2025.
Guidance, Outlook, and Risks
Outlook: The Company expects to complete purchases on US Trading Venues by December 19, 2025, as previously announced.
Risks and Contingencies: The filing states that these announcements do not constitute an offer or solicitation of an offer for securities in any jurisdiction. Full transaction details are available via the Market Abuse Regulation schedules linked in the original text.
Financial Metrics: The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Key Facts for Investor Verification
- Verify the total cumulative spend against the EUR 1 billion programme cap and the specific EUR 382 million final tranche allocation.
- Confirm the completion of the final tranche by the stated deadline of December 19, 2025.
- Monitor the impact of share cancellations on earnings per share (EPS) and total share count.
- Review the specific allocation shift between US and London trading venues for the final tranche.